Clinical Trial Update: Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System [Phase 3]

View source ↗

Summary

Phase 3 study updates the efficacy, safety and tolerability of Agile AG200-15 transdermal contraceptive system; completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• AG200-15 Transdermal Contraceptive Delivery System (levonorgestrel and ethinyl estradiol)

Snippet

Sponsor: Agile Therapeutics | Conditions: Healthy | Phase 3 | Status: COMPLETED | Results posted: 2017-09-25